Key statistics
On Thursday, Connect Biopharma Holdings Ltd (CNTB:NMQ) closed at 2.47, -24.70% below its 52-week high of 3.28, set on Nov 21, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.63 |
|---|---|
| High | 2.63 |
| Low | 2.46 |
| Bid | 2.08 |
| Offer | 3.44 |
| Previous close | 2.68 |
| Average volume | 93.95k |
|---|---|
| Shares outstanding | 55.90m |
| Free float | 33.14m |
| P/E (TTM) | -- |
| Market cap | 138.08m USD |
| EPS (TTM) | -0.9144 USD |
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
More ▼
- Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026
- Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference
- Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update
- Connect Biopharma Presents Data Supporting Rademikibart at the European Respiratory Society Congress 2025
- Connect Biopharma Announces Two Presentations at the European Respiratory Society (ERS) Congress 2025
- Connect Biopharma Completes Termination of its American Depositary Receipt Program and Directly Lists its Ordinary Shares on Nasdaq
- Connect Biopharma to Present at Two Upcoming Investor Conferences in September
- Connect Biopharma Teams with Ickey Woods and the Jovante Woods Foundation to Expand Asthma Education Program Nationwide
- Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update
- Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors
More ▼
